Skip to main content
Transcenta Holding Limited logo

Transcenta Holding Limited — Investor Relations & Filings

Ticker · 6628 ISIN · KYG9005B1041 HKEX Manufacturing
Open in API
Filings indexed 482 across all filing types
Latest filing 2024-03-05 Proxy Solicitation & In…
Country HK Hong Kong
Listing HKEX 6628

About Transcenta Holding Limited

http://www.transcenta.com

Transcenta Holding Limited is a clinical-stage global biotherapeutics company specializing in the discovery, research, development, and manufacturing of differentiated antibody-based therapeutics. The company operates a fully integrated platform, utilizing a unique antibody generation platform based on Immune Tolerance Breaking Technology to generate candidate leads. Its robust pipeline includes therapeutic antibody molecules targeting oncology and selected non-oncology indications, such as bone and kidney disorders. The company employs advanced bioprocessing technologies, including perfusion-based continuous bioprocessing, to accelerate process development and reduce manufacturing costs.

Recent filings

Filing Released Lang Actions
FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON MONDAY, MARCH 25, 2024
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Form of Proxy for an Extraordinary General Meeting (EGM) of Transcenta Holding Limited scheduled for March 25, 2024. It contains detailed voting instructions and resolutions related to share incentive schemes and awards to directors and executives. The content is procedural and related to shareholder voting rather than financial results, management changes, or regulatory filings. It is not a report or announcement of financial performance, nor is it a management or board change announcement. The document is specifically a proxy form used to facilitate voting at a shareholder meeting, which aligns with materials sent to shareholders to provide information and request votes for meetings. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI). The document length (11,704 characters) and detailed voting instructions confirm it is not a brief announcement or a report publication notice.
2024-03-05 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice of an Extraordinary General Meeting (EGM) for Transcenta Holding Limited. It includes details about the meeting date, location, and the resolutions to be voted on, specifically related to the grant of award shares under the company's Share Incentive Scheme. The document is a formal announcement inviting shareholders to attend and vote on these matters. It does not contain financial statements, management discussion, or detailed financial data. It is not a report or transcript but a meeting notice. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings such as EGMs.
2024-03-05 English
(1) GRANT OF AWARD SHARES UNDER SCHEME MANDATE LIMIT&#x3b; (2) ADDITIONAL GRANT OF AWARD SHARES BEYOND SCHEME MANDATE LIMIT&#x3b; (3) PROPOSED REFRESHMENT OF THE SCHEME MANDATE LIMIT AND SERVICE PROVI
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a circular issued by Transcenta Holding Limited concerning the grant of award shares under a share incentive scheme, additional grants beyond the scheme mandate limit, proposed refreshment of the scheme mandate limit and service provider sublimit, and notice of an Extraordinary General Meeting (EGM). It includes detailed information about the proposals to be voted on at the EGM, proxy arrangements, letters from the Independent Board Committee and Independent Financial Adviser, and the notice of the EGM itself. The document is not a financial report, earnings release, or regulatory filing but rather a solicitation of shareholder approval for specific corporate actions related to share awards and scheme limits. This type of document fits the definition of a Proxy Solicitation & Information Statement (PSI), which is used to provide shareholders with information and request votes for meetings, especially EGMs involving share incentive plans and related matters.
2024-03-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly return report on movements in securities, specifically focusing on share capital, issued shares, share options, and other share-related movements for Transcenta Holding Limited. It includes confirmations related to the issuance and listing of shares on the Hong Kong Stock Exchange. The document is structured as a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting on share capital changes and share issuance activities for the month ended January 31, 2024. It does not contain financial statements, earnings data, or management discussion, nor is it an announcement of a report publication. The content aligns with disclosures about share capital changes and share issuance, which fits the category of Share Issue/Capital Change filings.
2024-02-05 English
(1) GRANT OF AWARD SHARES UNDER SCHEME MANDATE LIMIT&#x3b; (2) ADDITIONAL GRANT OF AWARD SHARES BEYOND SCHEME MANDATE LIMIT&#x3b; AND (3) PROPOSED REFRESHMENT OF THE SCHEME MANDATE LIMIT AND SERVICE P
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from Transcenta Holding Limited regarding the grant of award shares under a share incentive scheme, including details about the number of shares granted, recipients (including directors and senior management), vesting periods, performance targets, clawback mechanisms, and the need for shareholder approval at an extraordinary general meeting (EGM) for certain grants exceeding scheme limits. The content focuses on share awards as part of remuneration and incentives, with references to Listing Rules and shareholder approvals. This type of document is a regulatory announcement about share-based compensation and capital changes, specifically about share awards and scheme mandate limits. It is not a full financial report, earnings release, or management discussion, nor is it a proxy statement or voting result. It is an announcement about share awards and related capital changes, fitting best under Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief announcement or a report publication notice, but a substantive announcement about share awards and capital changes.
2024-01-26 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return regarding movements in securities for Transcenta Holding Limited, including authorized share capital, issued shares, share options, repurchases, and confirmations related to securities issued. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules, specifically Chapter 19B. The document is a regulatory submission reporting share capital changes and share movements for the month ended December 31, 2023. It does not contain financial statements, earnings data, or management discussion, nor is it an announcement of a report publication. It is a regulatory filing reporting share capital and share issuance activities as required by the stock exchange rules. Therefore, it fits best under Regulatory Filings (RNS).
2024-01-04 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.